Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eye drops, pearl powder, nacre powder, weiweining granules, compound Kumu Xiaoyan tablets, etc. under the Haibao brand. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical, molecular diagnosis and forensic identification technical services, etc. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 and is based in Beihai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.7477560445904524 | N/A |
Market Cap | $391.97M | N/A |
Shares Outstanding | 524.20M | N/A |
Employees | 501.00 | N/A |